Ferroptosis targeting: A novel therapeutic regimen in diabetic cardiomyopathy

Area of Science:

• Cardiovascular Research
• Metabolic Diseases
• Cell Death Mechanisms

Background:

• Diabetic cardiomyopathy (DCM) is a major complication of diabetes mellitus (DM), causing myocardial dysfunction and remodeling.
• The underlying molecular mechanisms of DCM remain poorly understood, necessitating novel therapeutic approaches.
• Ferroptosis, an iron-dependent regulated cell death involving lipid peroxidation, has emerged as a key player in DCM pathogenesis.

Purpose of the Study:

• To review the molecular mechanisms of ferroptosis in the context of diabetic cardiomyopathy.
• To explore the role of ferroptosis regulation in the progression of DCM.
• To highlight emerging ferroptosis-inhibiting agents as potential therapeutic strategies for DCM.

Main Methods:

• Literature review of studies on ferroptosis and diabetic cardiomyopathy.
• Analysis of molecular pathways involved in ferroptosis and iron homeostasis in DCM.
• Evaluation of pharmacological agents targeting ferroptosis for cardioprotective effects in DCM models.

Main Results:

• Ferroptosis is critically involved in the development and progression of diabetic cardiomyopathy.
• Dysregulated iron homeostasis and lipid peroxidation are key features of ferroptosis in DCM.
• Several agents inhibiting ferroptosis have demonstrated significant cardioprotective effects in DCM models.

Conclusions:

• Ferroptosis is a crucial mechanism contributing to diabetic cardiomyopathy.
• Targeting ferroptosis pathways presents a promising novel therapeutic strategy for DCM.
• Pharmacological inhibition of ferroptosis holds potential for preventing and treating DCM.